aTyr Pharma Competitors and Similar CompaniesClear all

Catalyst Pharmaceuticals's competitors and similar companies include Merus.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Founding Date
Founding Date
2002
Founding Date
2003
Type
Type
Public
Type
Public
Tags
Locations
Locations
Coral Gables, US HQ
Locations
Utrecht, NL HQ
Cambridge, US
Employees
Employees
7649% increase
Employees
260
Valuation ($)
Valuation ($)
2.6 b
Valuation ($)
3.6 b

Financial

Revenue (est.)
Revenue (est.)
$589m (FY, 2025)
Revenue (est.)
$36.1m (FY, 2024)
Cost of goods
Cost of goods
$87.3m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$501.7m (FY, 2025)
Gross profit
$36.1m (FY, 2024)
Net income
Net income
$214.3m (FY, 2025)
Net income
($215.3m) (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Merus
HQ
Utrecht, NL
Employees
260

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company